<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00393731</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-04-008</org_study_id>
    <nct_id>NCT00393731</nct_id>
  </id_info>
  <brief_title>A Randomized, Control Trial for Preinduction Cervical Ripening</brief_title>
  <official_title>A Randomized, Control Trial for Preinduction Cervical Ripening</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <brief_summary>
    <textblock>
      The goal of this study is to compare the vaginal delivery rates in women undergoing induction
      of labor with an unripe cervix between oxytocin induction alone and preinduction cervical
      ripening with prostaglandin El (misoprostol). Secondary goals are to measure and compare the
      time intervals to delivery between the two methods.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2004</start_date>
  <completion_date type="Actual">August 2007</completion_date>
  <primary_completion_date type="Actual">August 2007</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vaginal Delivery rates</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time interval to delivery</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">540</enrollment>
  <condition>Labor, Induced</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Misoprostol</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>oxytocin</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women that are hospitalized for induction of labor that have a Bishop's score &lt;5

          -  singleton gestation

          -  cephalic presentation

          -  24 weeks gestational age

        Exclusion Criteria:

          -  Prior uterine surgery

          -  malpresentation

          -  placenta previa or abruption

          -  clinically suspected or diagnosed intra amniotic infection

          -  genital HSV infection

          -  multiple gestation

          -  premature rupture of the membranes

          -  active labor

          -  maternal/fetal conditions that may preclude labor induction in the opinion of the
             investigators
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Michael Lucas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lyndon B. Johnson Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77026</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 26, 2006</study_first_submitted>
  <study_first_submitted_qc>October 26, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 30, 2006</study_first_posted>
  <last_update_submitted>January 11, 2008</last_update_submitted>
  <last_update_submitted_qc>January 11, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 16, 2008</last_update_posted>
  <responsible_party>
    <name_title>Michael Lucas, M.D.</name_title>
    <organization>The University of Texas Health Science Center, Houston</organization>
  </responsible_party>
  <keyword>labor</keyword>
  <keyword>induction</keyword>
  <keyword>misoprostol</keyword>
  <keyword>oxytocin</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
    <mesh_term>Misoprostol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

